Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OXBRIDGE RE HOLDINGS Ltd Director's Dealing 2021

Apr 13, 2021

35082_dirs_2021-04-13_f85c401f-5e28-46aa-8d28-1db216a0e080.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXBRIDGE RE HOLDINGS Ltd (OXBR)
CIK: 0001584831
Period of Report: 2021-03-02

Reporting Person: CABILLOT RAYMOND E (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-02 Share Options (right to buy) $6.00 A 50000 Acquired 2031-03-02 Ordinary Shares (50000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares, Par Value $0.001 7225 Indirect
Ordinary Shares, Par Value $0.001 47045 Indirect
Ordinary Shares, Par Value $0.001 35000 Direct

Footnotes

F1: Shares indirectly held in the name of Farnam Street Capital for the benefit of and as the General Partner of FS Special Opportunities I Fund. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.

F2: Shares indirectly held in the name of Farnam Street Capital for the benefit of and as the General Partner of Farnam Street Partners. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.

F3: This option grant was previously reported on a Form 8-K filed by the issuer on March 8, 2021.

F4: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period.